|
US755047A
(en)
*
|
1902-03-17 |
1904-03-22 |
Alexander Roth Robertson |
Bottle-seal.
|
|
EP0009517A1
(en)
|
1978-10-04 |
1980-04-16 |
THE PROCTER & GAMBLE COMPANY |
Vaginal contraceptive
|
|
RU2139281C1
(ru)
|
1993-11-30 |
1999-10-10 |
Джи Ди Сирл энд Компани |
Пиразолилзамещенный бензолсульфонамид или его фармацевтически приемлемая соль, фармацевтическая композиция, способ лечения от воспаления или связанного с воспалением заболевания
|
|
US5844092A
(en)
|
1994-03-18 |
1998-12-01 |
Genentech, Inc. |
Human TRK receptors and neurotrophic factor inhibitors
|
|
US5430021A
(en)
|
1994-03-18 |
1995-07-04 |
Pharmavene, Inc. |
Hydrophobic drug delivery systems
|
|
US5877016A
(en)
|
1994-03-18 |
1999-03-02 |
Genentech, Inc. |
Human trk receptors and neurotrophic factor inhibitors
|
|
CN1163509C
(zh)
|
1996-05-08 |
2004-08-25 |
拜奥根有限公司 |
刺激神经和肾生长的RET配体(RetL)
|
|
US6677135B1
(en)
|
1996-05-08 |
2004-01-13 |
Biogen, Inc. |
Ret ligand (RetL) for stimulating neutral and renal growth
|
|
CA2206201A1
(en)
|
1996-05-29 |
1997-11-29 |
Yoshiaki Isobe |
Pyrazole derivatives and their pharmaceutical use
|
|
US6682921B1
(en)
|
1996-08-21 |
2004-01-27 |
New York University |
Crystals of the tyrosine kinase domain of non-insulin receptor tyrosine kinases
|
|
JP3898296B2
(ja)
|
1996-08-28 |
2007-03-28 |
ポーラ化成工業株式会社 |
ピロロピラゾロピリミジン化合物及びこれを有効成分とする医薬
|
|
AU7079998A
(en)
|
1997-04-25 |
1998-11-24 |
Takeda Chemical Industries Ltd. |
Condensed pyridazine derivatives, their production and use
|
|
US6531152B1
(en)
|
1998-09-30 |
2003-03-11 |
Dexcel Pharma Technologies Ltd. |
Immediate release gastrointestinal drug delivery system
|
|
UA74546C2
(en)
*
|
1999-04-06 |
2006-01-16 |
Boehringer Ingelheim Ca Ltd |
Macrocyclic peptides having activity relative to hepatitis c virus, a pharmaceutical composition and use of the pharmaceutical composition
|
|
WO2001016169A2
(en)
|
1999-09-01 |
2001-03-08 |
Biogen, Inc. |
RET LIGAND 5 (Retl5) FROM HUMAN AND MOUSE
|
|
US6534085B1
(en)
|
1999-09-23 |
2003-03-18 |
Bioresponse L.L.C. |
Phytochemicals for promoting weight loss
|
|
FI20000403A0
(fi)
|
2000-02-22 |
2000-02-22 |
Hannu Sariola |
GDNF perhesukuisten yhdisteiden käyttö kivessyövän hoitoon tarkoitettujen tuotteiden valmistamiseksi
|
|
KR100823764B1
(ko)
|
2000-06-22 |
2008-04-21 |
제넨테크, 인크. |
아고니스트 안티-티알케이-씨 모노클로날 항체
|
|
TWI312347B
(en)
|
2001-02-08 |
2009-07-21 |
Eisai R&D Man Co Ltd |
Bicyclic nitrogen-containing condensed ring compounds
|
|
CA2975521A1
(en)
|
2001-05-30 |
2002-12-05 |
Genentech, Inc. |
Anti-ngf antibodies for the treatment of various disorders
|
|
AU2002334355A1
(en)
|
2001-09-06 |
2003-03-18 |
Prochon Biotech Ltd. |
Protein tyrosine kinase inhibitors
|
|
US20030199525A1
(en)
|
2002-03-21 |
2003-10-23 |
Hirst Gavin C. |
Kinase inhibitors
|
|
US7662826B2
(en)
|
2002-04-23 |
2010-02-16 |
Shionogi & Co., Ltd. |
Pyrazolo [1,5-a] pyrimidine derivative and nad (p) h oxidase inhibitor containing the same
|
|
US7449488B2
(en)
|
2002-06-04 |
2008-11-11 |
Schering Corporation |
Pyrazolopyrimidines as protein kinase inhibitors
|
|
US20060116381A1
(en)
|
2002-07-24 |
2006-06-01 |
Fagin James A |
4-4(methylpiperazin-1-ylmethyl)-n-[4-methyl-3-(pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-ben-zamide for treating mutated-ret kinase associated diseases
|
|
JP4024624B2
(ja)
|
2002-08-26 |
2007-12-19 |
富士通株式会社 |
半導体装置の製造方法及び製造装置
|
|
US8580782B2
(en)
|
2002-09-04 |
2013-11-12 |
Merck Sharp & Dohme Corp. |
Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors
|
|
EP1537116B1
(en)
|
2002-09-04 |
2010-06-02 |
Schering Corporation |
Pyrazolopyrimidines suitable for the treatment of cancer diseases
|
|
US7196078B2
(en)
|
2002-09-04 |
2007-03-27 |
Schering Corpoartion |
Trisubstituted and tetrasubstituted pyrazolopyrimidines as cyclin dependent kinase inhibitors
|
|
US7119200B2
(en)
|
2002-09-04 |
2006-10-10 |
Schering Corporation |
Pyrazolopyrimidines as cyclin dependent kinase inhibitors
|
|
RU2357967C2
(ru)
*
|
2002-09-16 |
2009-06-10 |
Глаксо Груп Лимитед |
ПРОИЗВОДНЫЕ ПИРАЗОЛО[3, 4-b]ПИРИДИНА, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ (ВАРИАНТЫ), ПРИМЕНЕНИЕ (ВАРИАНТЫ), КОМПОЗИЦИЯ (ВАРИАНТЫ)
|
|
WO2004052315A2
(en)
|
2002-12-11 |
2004-06-24 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
|
WO2004052286A2
(en)
|
2002-12-11 |
2004-06-24 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
|
GB0303910D0
(en)
|
2003-02-20 |
2003-03-26 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
US20070037150A1
(en)
|
2003-02-21 |
2007-02-15 |
The Johns Hopkins University |
Tyrosine kinome
|
|
JP2004277337A
(ja)
*
|
2003-03-14 |
2004-10-07 |
Sumitomo Pharmaceut Co Ltd |
ピラゾロ［１，５−ａ］ピリミジン誘導体
|
|
EP1608652A1
(en)
|
2003-03-31 |
2005-12-28 |
Vernalis (Cambridge) Limited |
Pyrazolopyrimidine compounds and their use in medicine
|
|
WO2004089415A2
(en)
|
2003-04-11 |
2004-10-21 |
Novo Nordisk A/S |
COMBINATIONS OF AN 11β-HYDROXYSTEROID DEHYDROGENASE TYPE 1 INHIBITOR AND A GLUCOCORTICOID RECEPTOR AGONIST
|
|
US20060094699A1
(en)
|
2003-04-11 |
2006-05-04 |
Kampen Gita Camilla T |
Combination therapy using an 11beta-hydroxysteroid dehydrogenase type 1 inhibitor and a glucocorticoid receptor agonist to minimize the side effects associated with glucocorticoid receptor agonist therapy
|
|
WO2004089471A2
(en)
|
2003-04-11 |
2004-10-21 |
Novo Nordisk A/S |
NEW PYRAZOLO[1,5-a] PYRIMIDINES DERIVATIVES AND PHARMACEUTICAL USE THEREOF
|
|
KR20060011977A
(ko)
|
2003-04-28 |
2006-02-06 |
가르파마 컴퍼니 리미티드 |
갈렉틴 9 유도 인자
|
|
PA8603801A1
(es)
*
|
2003-05-27 |
2004-12-16 |
Janssen Pharmaceutica Nv |
Derivados de la quinazolina
|
|
JP2005008581A
(ja)
|
2003-06-20 |
2005-01-13 |
Kissei Pharmaceut Co Ltd |
新規なピラゾロ［１，５−ａ］ピリミジン誘導体、それを含有する医薬組成物およびそれらの用途
|
|
CN1849138B
(zh)
|
2003-07-15 |
2011-11-30 |
安姆根有限公司 |
作为选择性ngf途径抑制剂的人抗ngf中和抗体
|
|
UY28525A1
(es)
*
|
2003-09-22 |
2005-04-29 |
Boehringer Ingelheim Int |
Péptidos macrociclicos activos contra en virus de la hepatitis c
|
|
US20090143399A1
(en)
|
2003-10-14 |
2009-06-04 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Protein Kinase Inhibitors
|
|
US7491794B2
(en)
*
|
2003-10-14 |
2009-02-17 |
Intermune, Inc. |
Macrocyclic compounds as inhibitors of viral replication
|
|
MY141220A
(en)
|
2003-11-17 |
2010-03-31 |
Astrazeneca Ab |
Pyrazole derivatives as inhibitors of receptor tyrosine kinases
|
|
PT1687305E
(pt)
|
2003-11-21 |
2008-10-17 |
Novartis Ag |
Derivados de 1h-imidazoquinolina como inibidores de proteína quinase
|
|
WO2005051366A2
(en)
|
2003-11-28 |
2005-06-09 |
Novartis Ag |
Diaryl urea derivatives in the treatment of protein kinase dependent diseases
|
|
EP1697384B1
(en)
*
|
2003-12-18 |
2008-04-02 |
Janssen Pharmaceutica N.V. |
Pyrido- and pyrimidopyrimidine derivatives as anti-proliferative agents
|
|
CN1925855B
(zh)
|
2003-12-19 |
2010-06-16 |
普莱希科公司 |
开发Ret调节剂的化合物和方法
|
|
GB0330043D0
(en)
|
2003-12-24 |
2004-01-28 |
Pharmacia Italia Spa |
Pyrrolo [2,3-b] pyridine derivatives active as kinase inhibitors process for their preparation and pharmaceutical compositions comprising them
|
|
GB0330042D0
(en)
|
2003-12-24 |
2004-01-28 |
Pharmacia Italia Spa |
Pyrrolo [2,3-b] pyridine derivatives active as kinase inhibitors process for their preparation and pharmaceutical compositions them
|
|
PE20051089A1
(es)
|
2004-01-22 |
2006-01-25 |
Novartis Ag |
Derivados de pirazolo [1,5-a] pirimidin-7-il-amina como inhibidores de quinasa de proteina
|
|
US20050222171A1
(en)
|
2004-01-22 |
2005-10-06 |
Guido Bold |
Organic compounds
|
|
WO2005099363A2
(en)
|
2004-03-26 |
2005-10-27 |
Whitehead Institute For Biomedical Research |
Methods of diagnosing, preventing and treating cancer metastasis
|
|
CN1938311A
(zh)
*
|
2004-03-30 |
2007-03-28 |
因特蒙公司 |
作为病毒复制抑制剂的大环化合物
|
|
EP2329902A1
(en)
|
2004-06-25 |
2011-06-08 |
Mitsubishi Materials Corporation |
Metal colloid particles, metal colloid and use of the colloid
|
|
EP1797054A2
(en)
|
2004-08-02 |
2007-06-20 |
OSI Pharmaceuticals, Inc. |
Aryl-amino substituted pyrrolopyrimidine multi-kinase inhibiting compounds
|
|
PE20060664A1
(es)
|
2004-09-15 |
2006-08-04 |
Novartis Ag |
Amidas biciclicas como inhibidores de cinasa
|
|
WO2006050076A1
(en)
|
2004-10-29 |
2006-05-11 |
Janssen Pharmaceutica, N.V. |
Pyrimidinyl substituted fused-pyrrolyl compounds useful in treating kinase disorders
|
|
WO2007011410A1
(en)
|
2004-10-29 |
2007-01-25 |
North Carolina State University |
Production of an asporogenic strain of bacillus licheniformis and its use for the production of keratinase
|
|
US7452847B2
(en)
|
2004-11-02 |
2008-11-18 |
Ricoh Company, Ltd. |
Reversible thermosensitive recording medium, reversible thermosensitive recording label, reversible thermosensitive recording device, image processing apparatus, and image processing method
|
|
EP1812440B1
(en)
|
2004-11-04 |
2010-09-22 |
Vertex Pharmaceuticals, Inc. |
Pyrazolo[1,5-a]pyrimidines useful as inhibitors of protein kinases
|
|
JO3088B1
(ar)
*
|
2004-12-08 |
2017-03-15 |
Janssen Pharmaceutica Nv |
مشتقات كوينازولين كبيرة الحلقات و استعمالها بصفتها موانع كينيز متعددة الاهداف
|
|
DE102005003687A1
(de)
|
2005-01-26 |
2006-07-27 |
Sphingo Tec Gmbh |
Immunoassay zur Bestimmung der Freisetzung von Neurotensin in die Zirkulation
|
|
GB0501999D0
(en)
|
2005-02-01 |
2005-03-09 |
Sentinel Oncology Ltd |
Pharmaceutical compounds
|
|
EP1853602B1
(en)
|
2005-02-16 |
2010-07-14 |
AstraZeneca AB |
Chemical compounds
|
|
CN101119996A
(zh)
|
2005-02-16 |
2008-02-06 |
阿斯利康(瑞典)有限公司 |
化学化合物
|
|
WO2006089298A2
(en)
|
2005-02-18 |
2006-08-24 |
Attenuon, Llc |
Pyrimidine-fused diazepine derivatives and indole-fused pteridines
|
|
PL1869049T3
(pl)
*
|
2005-03-21 |
2009-07-31 |
Lilly Co Eli |
Związki imidazopirydazyny
|
|
GB0507575D0
(en)
|
2005-04-14 |
2005-05-18 |
Novartis Ag |
Organic compounds
|
|
US7402579B2
(en)
|
2005-04-15 |
2008-07-22 |
Cylene Pharmaceuticals, Inc. |
Quinobenzoxazine analogs and compositions
|
|
CN101208093A
(zh)
|
2005-04-27 |
2008-06-25 |
阿斯利康(瑞典)有限公司 |
吡唑-嘧啶衍生物在治疗疼痛中的用途
|
|
BRPI0610184A2
(pt)
|
2005-05-16 |
2012-09-25 |
Astrazeneca Ab |
composto, sal farmaceuticamente aceitável de um composto, processo para preparar um composto ou um sal farmaceuticamente aceitável do mesmo, uso de um composto ou um sal farmaceuticamente aceitável do mesmo, métodos para a inibição da atividade de trk, para o tratamento ou profilaxia de cáncer e para a produção de um efeito anti-proliferativo em um animal de sanque quente, e, composição farmacêutica
|
|
WO2006128042A2
(en)
|
2005-05-26 |
2006-11-30 |
The Johns Hopkins University |
Methods of identifying mutations in nucleic acid
|
|
WO2006130673A1
(en)
|
2005-05-31 |
2006-12-07 |
Janssen Pharmaceutica, N.V. |
3-benzoimidazolyl-pyrazolopyridines useful in treating kinase disorders
|
|
CN101233129A
(zh)
|
2005-05-31 |
2008-07-30 |
普法尔家族联合企业（1996.7.9） |
取代的联芳杂环衍生物作为蛋白激酶抑制剂治疗癌症及其他疾病
|
|
CN100406650C
(zh)
|
2005-06-05 |
2008-07-30 |
徐斌 |
一种抗特大变位的模块式梳型桥梁伸缩缝装置
|
|
ITRM20050290A1
(it)
|
2005-06-07 |
2006-12-08 |
Lay Line Genomics Spa |
Uso di molecole in grado di inibire il legame tra ngf e il suo recettore trka come analgesici ad effetto prolungato.
|
|
PL2395004T3
(pl)
|
2005-06-22 |
2016-08-31 |
Plexxikon Inc |
Pochodne pirolo[2,3-b]pirydyny jako inhibitory kinazy białkowej
|
|
US20070025540A1
(en)
|
2005-07-07 |
2007-02-01 |
Roger Travis |
Call center routing based on talkativeness
|
|
GB0515026D0
(en)
|
2005-07-21 |
2005-08-31 |
Novartis Ag |
Organic compounds
|
|
KR101294467B1
(ko)
*
|
2005-07-25 |
2013-09-09 |
인터뮨, 인크. |
Ｃ형 간염 바이러스 복제의 신규 거대고리형 억제제
|
|
EP1910369A1
(en)
|
2005-07-29 |
2008-04-16 |
Astellas Pharma Inc. |
Fused heterocycles as lck inhibitors
|
|
WO2007019058A1
(en)
|
2005-08-03 |
2007-02-15 |
Eastman Chemical Company |
Tocopheryl polyethylene glycol succinate powder and process for preparing same
|
|
AU2006283592A1
(en)
|
2005-08-22 |
2007-03-01 |
Amgen Inc. |
Pyrazolopyridine and pyrazolopyrimidine compounds useful as kinase enzymes modulators
|
|
RS53195B2
(sr)
|
2005-08-25 |
2018-08-31 |
Creabilis Therapeutics Spa |
Polimerni konjugati k-252a i njihovi derivati
|
|
WO2007025090A2
(en)
|
2005-08-25 |
2007-03-01 |
Kalypsys, Inc. |
Heterobicyclic and - tricyclic inhibitors of mapk/erk kinase
|
|
DE102005042742A1
(de)
|
2005-09-02 |
2007-03-08 |
Schering Ag |
Substituierte Imidazo[1,2b]pyridazine als Kinase-Inhibitoren, deren Herstellung und Verwendung als Arzneimittel
|
|
US20070078136A1
(en)
|
2005-09-22 |
2007-04-05 |
Bristol-Myers Squibb Company |
Fused heterocyclic compounds useful as kinase modulators
|
|
CN101360499B
(zh)
|
2005-10-06 |
2015-10-07 |
默沙东公司 |
吡唑并[1,5-a]嘧啶衍生物在制备抑制蛋白激酶的药物中的用途
|
|
AR057979A1
(es)
|
2005-10-06 |
2008-01-09 |
Schering Corp |
PIRAZOLPIRIMIDINAS COMO INHIBIDORAS DE PROTEíNA QUINASA. COMPOSICIONES FARMACEUTICAS.
|
|
BRPI0617274A2
(pt)
*
|
2005-10-11 |
2011-07-19 |
Intermune Inc |
compostos e métodos para a inibição de replicação viral de hepatite c
|
|
WO2007057782A2
(en)
|
2005-10-11 |
2007-05-24 |
Centre National De La Recherche Scientifique (Cnrs) |
3 -hydroxyflavone derivatives for the detection and the quantification of cell apoptosis
|
|
JP5119157B2
(ja)
|
2005-10-21 |
2013-01-16 |
エクセリクシス， インク． |
カゼインキナーゼｉｉ（ｃｋ２）モジュレーターとしてのピラゾロ−ピリミジン類
|
|
JP2009519218A
(ja)
|
2005-11-03 |
2009-05-14 |
エスジーエックス ファーマシューティカルズ、インコーポレイテッド |
ピリミジニル−チオフェンキナーゼモジュレータ
|
|
EP1785420A1
(en)
|
2005-11-14 |
2007-05-16 |
4Sc Ag |
Thiazole analogues and uses thereof
|
|
US20070149523A1
(en)
|
2005-11-14 |
2007-06-28 |
Jan Ehlert |
Thiazole Analogues and Uses Thereof
|
|
WO2007057397A1
(en)
|
2005-11-15 |
2007-05-24 |
Boehringer Ingelheim International Gmbh |
Treatment of cancer
|
|
GB0524436D0
(en)
|
2005-11-30 |
2006-01-11 |
Novartis Ag |
Organic compounds
|
|
AU2006322187A1
(en)
|
2005-12-08 |
2007-06-14 |
Novartis Ag |
Pyrazolo[1,5-a]pyridine-3-carboxylic acids as EphB and VEGFR2 kinase inhibitors
|
|
WO2007084815A2
(en)
|
2006-01-19 |
2007-07-26 |
Janssen Pharmaceutica, N.V. |
Substituted thienopyrimidine kinase inhibitors
|
|
JP5256047B2
(ja)
|
2006-01-27 |
2013-08-07 |
シャンハイ ヘンルイ ファーマシューティカル カンパニー リミテッド |
ピロロ［３，２−ｃ］ピリジン−４−オン２−インドリノン（ｉｎｄｏｌｉｎｏｎｅ）プロテインキナーゼ阻害剤
|
|
WO2007102679A1
(en)
|
2006-03-06 |
2007-09-13 |
Je Il Pharmaceutical Co., Ltd. |
Novel thienopyrimidine derivatives or pharmaceutically acceptable salts thereof, process for the preparation thereof and pharmaceutical composition comprising the same
|
|
CA2645137A1
(en)
|
2006-03-07 |
2007-09-13 |
James F. Blake |
Heterobicyclic pyrazole compounds and methods of use
|
|
CN101563336A
(zh)
|
2006-03-16 |
2009-10-21 |
诺瓦提斯公司 |
用于治疗特别是黑素瘤的杂环有机化合物
|
|
KR101549364B1
(ko)
|
2006-03-17 |
2015-09-01 |
암비트 바이오사이언시즈 코포레이션 |
질환 치료용 이미다졸로티아졸 화합물
|
|
GB0606805D0
(en)
|
2006-04-04 |
2006-05-17 |
Novartis Ag |
Organic compounds
|
|
KR101533461B1
(ko)
|
2006-04-26 |
2015-07-02 |
에프. 호프만-라 로슈 아게 |
Ｐｉ３ｋ저해제로 유용한 티에노［3,2-ｄ］피리미딘 유도체
|
|
MX2008014618A
(es)
|
2006-05-15 |
2008-11-28 |
Irm Llc |
Composiciones y metodos para inhibidores de cinasas del receptor fgf.
|
|
US7389632B2
(en)
|
2006-06-10 |
2008-06-24 |
Uhlmann Pac-Systeme Gmbh & Co. Kg |
Apparatus for distributing small objects in a fill station
|
|
EP1873157A1
(en)
*
|
2006-06-21 |
2008-01-02 |
Bayer Schering Pharma Aktiengesellschaft |
Pyrazolopyrimidines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
|
|
TW201345908A
(zh)
|
2006-07-05 |
2013-11-16 |
Mitsubishi Tanabe Pharma Corp |
吡唑并〔１，５-ａ〕嘧啶化合物
|
|
EP2058309A4
(en)
|
2006-08-04 |
2010-12-22 |
Takeda Pharmaceutical |
CONDENSED HETEROCYCLIC COMPOUND
|
|
US7531539B2
(en)
|
2006-08-09 |
2009-05-12 |
Bristol-Myers Squibb Company |
Pyrrolotriazine kinase inhibitors
|
|
US8063225B2
(en)
|
2006-08-14 |
2011-11-22 |
Chembridge Corporation |
Tricyclic compound derivatives useful in the treatment of neoplastic diseases, inflammatory disorders and immunomodulatory disorders
|
|
CA2663091A1
(en)
|
2006-09-07 |
2008-03-13 |
Biogen Idec Ma Inc. |
Modulators of interleukin-1 receptor-associated kinase
|
|
US20110195072A1
(en)
|
2006-09-12 |
2011-08-11 |
Anne Boulay |
Non-neuroendocrine cancer therapy
|
|
KR101507375B1
(ko)
|
2006-09-15 |
2015-04-07 |
엑스커버리 홀딩 컴퍼니 엘엘씨 |
키나아제 억제제 화합물
|
|
RU2009115954A
(ru)
|
2006-09-29 |
2010-11-10 |
Новартис АГ (CH) |
Пиразолопиримидины в качестве ингибиторов липидной киназы р13к
|
|
US20120225057A1
(en)
|
2006-10-11 |
2012-09-06 |
Deciphera Pharmaceuticals, Llc |
Methods and compositions for the treatment of myeloproliferative diseases and other proliferative diseases
|
|
EP1918291A1
(en)
|
2006-10-30 |
2008-05-07 |
Novartis AG |
3-Aminocarbonyl-substituted fused pyrazolo-derivatives as protein kinase modulators
|
|
JP2010508315A
(ja)
|
2006-10-30 |
2010-03-18 |
ノバルティス アーゲー |
抗炎症剤としてのヘテロ環式化合物
|
|
WO2008058126A2
(en)
|
2006-11-06 |
2008-05-15 |
Supergen, Inc. |
Imidazo[1,2-b]pyridazine and pyrazolo[1,5-a]pyrimidine derivatives and their use as protein kinase inhibitors
|
|
EP2099774A4
(en)
|
2006-11-15 |
2010-11-24 |
Ym Biosciences Australia Pty L |
INHIBITORS OF KINASEACTIVITY
|
|
US8741849B2
(en)
|
2007-01-10 |
2014-06-03 |
Purdue Research Foundation |
Kinase inhibitors and uses thereof
|
|
US20080199426A1
(en)
|
2007-01-11 |
2008-08-21 |
Sukhatme Vikas P |
Methods and compositions for the treatment and diagnosis of vascular inflammatory disorders or endothelial cell disorders
|
|
CA2675979A1
(en)
|
2007-01-19 |
2008-07-24 |
Bayer Healthcare Llc |
Treatment of cancers having resistance to chemotherapeutic agents
|
|
BRPI0807087A2
(pt)
*
|
2007-02-08 |
2014-06-10 |
Tibotec Pharm Ltd |
Inibidores de hcv macrocíclicos substituídos de pirimidina
|
|
US20080234267A1
(en)
|
2007-03-20 |
2008-09-25 |
Karen Elizabeth Lackey |
Compounds and Methods of Treatment
|
|
US20080234262A1
(en)
|
2007-03-21 |
2008-09-25 |
Wyeth |
Pyrazolopyrimidine analogs and their use as mtor kinase and pi3 kinase inhibitors
|
|
CN101801972A
(zh)
|
2007-03-28 |
2010-08-11 |
英诺瓦西亚公司 |
作为硬脂酰-辅酶a去饱和酶抑制剂的吡唑并[1,5-a]嘧啶
|
|
WO2008124323A1
(en)
|
2007-04-03 |
2008-10-16 |
Array Biopharma Inc. |
Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitors
|
|
US20110189167A1
(en)
|
2007-04-20 |
2011-08-04 |
Flynn Daniel L |
Methods and Compositions for the Treatment of Myeloproliferative Diseases and other Proliferative Diseases
|
|
EA019524B1
(ru)
|
2007-05-04 |
2014-04-30 |
Айрм Ллк |
СОЕДИНЕНИЯ И КОМПОЗИЦИИ КАК ИНГИБИТОРЫ КИНАЗЫ с-kit И PDGFR
|
|
WO2008138184A1
(fr)
|
2007-05-14 |
2008-11-20 |
Shanghai Hengrui Pharmaceutical Co.Ltd. |
Dérivés de pyrrolo-azacycles, leur procédé de fabrication et leur utilisation en tant qu'inhibiteurs de protéine kinases
|
|
CA2687909C
(en)
*
|
2007-06-21 |
2015-09-15 |
Janssen Pharmaceutica Nv |
Indolin-2-ones and aza-indolin-2-ones
|
|
US20090012045A1
(en)
|
2007-06-26 |
2009-01-08 |
Rigel Pharmaceuticals, Inc. |
Methods of Treating Cell Proliferative Disorders
|
|
US20100209488A1
(en)
|
2007-07-16 |
2010-08-19 |
The Regents Of The University Of California |
Protein kinase modulating compounds and methods for making and using them
|
|
EA018503B1
(ru)
|
2007-07-20 |
2013-08-30 |
НЕРВИАНО МЕДИКАЛ САЙЕНСИЗ С.р.л. |
Замещенные производные индазола, активные как ингибиторы киназы
|
|
KR101709488B1
(ko)
|
2007-08-10 |
2017-02-24 |
리제너론 파아마슈티컬스, 인크. |
인간 신경성장인자에 대한 고친화성 인간 항체
|
|
EP2025678A1
(en)
|
2007-08-17 |
2009-02-18 |
Oncalis AG |
Pyrazolo[3,4-d]pyrimidine compounds and their use as modulators of protein kinase
|
|
WO2009042646A1
(en)
|
2007-09-24 |
2009-04-02 |
Curis, Inc. |
Anti-proliferative agents
|
|
CN101883774A
(zh)
|
2007-10-16 |
2010-11-10 |
惠氏有限责任公司 |
噻吩并嘧啶和吡唑并嘧啶化合物及其用作mtor激酶和pi3激酶抑制剂的用途
|
|
EA201000603A1
(ru)
|
2007-10-23 |
2010-12-30 |
Новартис Аг |
ПРИМЕНЕНИЕ АНТИТЕЛ К TrkB ДЛЯ ЛЕЧЕНИЯ РЕСПИРАТОРНЫХ НАРУШЕНИЙ
|
|
WO2009060197A1
(en)
|
2007-11-08 |
2009-05-14 |
Centro Nacional De Investigaciones Oncologicas (Cnio) |
Imidazopyridazines for use as protein kinase inhibitors
|
|
WO2009070567A1
(en)
|
2007-11-28 |
2009-06-04 |
Schering Corporation |
2-fluoropyrazolo[1,5-a]pyrimidines as protein kinase inhibitors
|
|
CN102015769B
(zh)
|
2008-01-17 |
2014-12-10 |
Irm责任有限公司 |
改进的抗-trkb抗体
|
|
TW200938542A
(en)
|
2008-02-01 |
2009-09-16 |
Irm Llc |
Compounds and compositions as kinase inhibitors
|
|
WO2009103076A1
(en)
|
2008-02-15 |
2009-08-20 |
Oxigene, Inc. |
Methods and compositions for enhancing the efficacy of rtk inhibitors
|
|
WO2009117097A1
(en)
|
2008-03-19 |
2009-09-24 |
Chembridge Corporation |
Novel tyrosine kinase inhibitors
|
|
EA019507B1
(ru)
|
2008-05-13 |
2014-04-30 |
Айрм Ллк |
Конденсированные азотсодержащие гетероциклы и содержащие их композиции в качестве ингибиторов киназы
|
|
WO2009155527A2
(en)
|
2008-06-19 |
2009-12-23 |
Progenics Pharmaceuticals, Inc. |
Phosphatidylinositol 3 kinase inhibitors
|
|
CA2730190A1
(en)
|
2008-07-14 |
2010-01-21 |
Queen's University At Kingston |
Pharmaceutical compositions comprising ret inhibitors and methods for the treatment of cancer
|
|
ES2532732T3
(es)
|
2008-07-29 |
2015-03-31 |
Nerviano Medical Sciences S.R.L. |
Uso de un inhibidor de CDK para el tratamiento del glioma
|
|
US20100075916A1
(en)
|
2008-09-05 |
2010-03-25 |
Auspex Pharmaceuticals, Inc. |
Substituted quinazoline inhibitors of growth factor receptor tyrosine kinases
|
|
EP2161271A1
(en)
|
2008-09-08 |
2010-03-10 |
Università Degli Studi Di Milano - Bicocca |
Alpha-carboline inhibitors of NMP-ALK, RET, and Bcr-Abl
|
|
DK2350075T3
(da)
|
2008-09-22 |
2014-05-26 |
Array Biopharma Inc |
Substituerede imidazo[1,2b]pyridazinforbindelser som trk-kinase-inhibitorer
|
|
ES2435918T3
(es)
|
2008-09-26 |
2013-12-26 |
National Health Research Institutes |
Compuestos multicíclicos condensados como inhibidores de las proteína-cinasas
|
|
PT3106463T
(pt)
|
2008-10-22 |
2018-05-18 |
Array Biopharma Inc |
Compostos de pirazolo[1,5-]pirimidina substituídos como inibidores de cinase trk
|
|
RU2539568C2
(ru)
|
2008-10-31 |
2015-01-20 |
Дженентек, Инк. |
Пиразолопиримидиновые соединения-ингибиторы jak и способы
|
|
EP2358725A1
(en)
|
2008-11-06 |
2011-08-24 |
Ambit Biosciences Corporation |
Imidazolothiazole compounds as modulators of protein kinase
|
|
CN102223885B
(zh)
|
2008-11-24 |
2013-04-03 |
内尔维阿诺医学科学有限公司 |
用于治疗间皮瘤的cdk抑制剂
|
|
KR101061599B1
(ko)
|
2008-12-05 |
2011-09-02 |
한국과학기술연구원 |
비정상 세포 성장 질환의 치료를 위한 단백질 키나아제 저해제인 신규 인다졸 유도체, 이의 약학적으로 허용가능한염 및 이를 유효성분으로 함유하는 약학적 조성물
|
|
DK2881402T3
(en)
|
2009-02-12 |
2017-08-28 |
Cell Signaling Technology Inc |
Mutant ROS expression in human liver cancer
|
|
TWI410418B
(zh)
|
2009-04-29 |
2013-10-01 |
Ind Tech Res Inst |
氮雜薁化合物、藥學組合物與抑制一細胞中蛋白質激酶之活性的方法
|
|
CA2760061C
(en)
|
2009-05-08 |
2017-02-28 |
Astellas Pharma Inc. |
Diamino heterocyclic carboxamide compound
|
|
WO2010144909A1
(en)
|
2009-06-12 |
2010-12-16 |
Novartis Ag |
Fused heterocyclic compounds and their uses
|
|
AR077468A1
(es)
|
2009-07-09 |
2011-08-31 |
Array Biopharma Inc |
Compuestos de pirazolo (1,5 -a) pirimidina sustituidos como inhibidores de trk- quinasa
|
|
KR101256018B1
(ko)
|
2009-08-20 |
2013-04-18 |
한국과학기술연구원 |
단백질 키나아제 저해활성을 갖는 1,3,6-치환된 인돌 화합물
|
|
KR101147550B1
(ko)
|
2009-10-22 |
2012-05-17 |
한국과학기술연구원 |
단백질 키나아제 저해활성을 가지는 2,7-치환된 티에노［3,2-ｄ］피리미딘 화합물
|
|
KR101116756B1
(ko)
|
2009-10-27 |
2012-03-13 |
한국과학기술연구원 |
단백질 키나아제 저해활성을 갖는 신규의 1,6-치환된 인돌 화합물
|
|
ES2658290T3
(es)
|
2009-10-29 |
2018-03-09 |
Genosco |
Inhibidores de cinasa
|
|
JP5740409B2
(ja)
|
2009-11-13 |
2015-06-24 |
ジェノスコ |
キナーゼ阻害剤
|
|
KR101094446B1
(ko)
|
2009-11-19 |
2011-12-15 |
한국과학기술연구원 |
단백질 키나아제 저해활성을 가지는 2,4,7-치환된 티에노［3,2-ｄ］피리미딘 화합물
|
|
US9180127B2
(en)
|
2009-12-29 |
2015-11-10 |
Dana-Farber Cancer Institute, Inc. |
Type II Raf kinase inhibitors
|
|
KR101483215B1
(ko)
|
2010-01-29 |
2015-01-16 |
한미약품 주식회사 |
단백질 키나아제 저해활성을 갖는 비시클릭 헤테로아릴 유도체
|
|
CA2786438C
(en)
|
2010-01-29 |
2015-10-13 |
Hanmi Science Co., Ltd. |
Thieno[3,2-d]pyrimidine derivatives having inhibitory activity on protein kinases
|
|
EP2536414B1
(en)
|
2010-02-18 |
2016-07-13 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Method for preventing cancer metastasis
|
|
KR20130043104A
(ko)
|
2010-04-06 |
2013-04-29 |
카리스 라이프 사이언스 룩셈부르크 홀딩스 |
질병용 순환 생물학적 지표들
|
|
US8383793B2
(en)
|
2010-04-15 |
2013-02-26 |
St. Jude Children's Research Hospital |
Methods and compositions for the diagnosis and treatment of cancer resistant to anaplastic lymphoma kinase (ALK) kinase inhibitors
|
|
TWI619713B
(zh)
|
2010-04-21 |
2018-04-01 |
普雷辛肯公司 |
用於激酶調節的化合物和方法及其適應症
|
|
US8543395B2
(en)
|
2010-05-18 |
2013-09-24 |
Shazam Entertainment Ltd. |
Methods and systems for performing synchronization of audio with corresponding textual transcriptions and determining confidence values of the synchronization
|
|
RU2735545C2
(ru)
|
2010-05-20 |
2020-11-03 |
Эррэй Биофарма Инк. |
Макроциклические соединения в качестве ингибиторов киназы trk
|
|
JP6121903B2
(ja)
|
2010-08-19 |
2017-04-26 |
ゾエティス・ベルジャム・エス・アー |
抗ｎｇｆ抗体およびその使用
|
|
WO2012034095A1
(en)
|
2010-09-09 |
2012-03-15 |
Irm Llc |
Compounds and compositions as trk inhibitors
|
|
UY33597A
(es)
|
2010-09-09 |
2012-04-30 |
Irm Llc |
Compuestos y composiciones como inhibidores de la trk
|
|
WO2012037155A2
(en)
|
2010-09-13 |
2012-03-22 |
Gtx, Inc. |
Tyrosine kinase inhibitors
|
|
WO2012047017A2
(ko)
|
2010-10-05 |
2012-04-12 |
크리스탈지노믹스(주) |
2,3-디히드로-이소인돌-1-온 유도체 및 이를 포함하는 조성물
|
|
KR20190112175A
(ko)
|
2010-12-01 |
2019-10-02 |
앨더바이오 홀딩스 엘엘씨 |
항―ｎｇｆ 조성물 및 그의 용도
|
|
US8618146B2
(en)
|
2011-01-03 |
2013-12-31 |
Dr. Reddy's Laboratories Limited |
Epothilone compound formulations
|
|
CN102093421B
(zh)
|
2011-01-28 |
2014-07-02 |
北京康辰药业有限公司 |
一种含磷取代基的喹啉类化合物及其制备方法、以及含有该化合物的药物组合物及其应用
|
|
KR20140014184A
(ko)
|
2011-02-25 |
2014-02-05 |
아이알엠 엘엘씨 |
Trk 억제제로서의 화합물 및 조성물
|
|
WO2012135631A1
(en)
|
2011-03-30 |
2012-10-04 |
Arrien Pharmaeuticals Llc |
Substituted 5-(pyrazin-2-yl)-1h-pyrazolo [3, 4-b] pyridine and pyrazolo [3, 4-b] pyridine derivatives as protein kinase inhibitors
|
|
ES2759615T3
(es)
|
2011-04-01 |
2020-05-11 |
Univ Utah Res Found |
Análogos de N-fenilpirimidina-2-amina sustituidos como inhibidores de la quinasa AXL
|
|
MY173181A
(en)
|
2011-05-13 |
2020-01-02 |
Array Biopharma Inc |
Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as trka kinase inhibitors
|
|
RU2477723C2
(ru)
|
2011-06-16 |
2013-03-20 |
Общество С Ограниченной Ответственностью "Фьюжн Фарма" |
Ингибиторы протеинкиназ (варианты), их применение для лечения онкологических заболеваний и фармацевтическая композиция на их основе
|
|
WO2013016720A2
(en)
|
2011-07-28 |
2013-01-31 |
Gerinda Therapeutics, Inc. |
Novel substituted biarylheterocycle derivatives as protein kinase inhibitors for the treatment of cancer and other diseases
|
|
US9216172B2
(en)
|
2011-08-04 |
2015-12-22 |
National Cancer Center |
Method for determining effectiveness of cancer treatment by assessing the presence of a KIF5B-RET chimeric gene
|
|
WO2013028817A1
(en)
|
2011-08-23 |
2013-02-28 |
Foundation Medicine , Inc. |
Novel kif5b-ret fusion molecules and uses thereof
|
|
MX370814B
(es)
|
2011-09-02 |
2020-01-08 |
Univ California |
Pirazolo[3,4-d]pirimidinas sustituidas y usos de las mismas.
|
|
WO2013036232A2
(en)
|
2011-09-08 |
2013-03-14 |
Deciphera Pharmaceuticals, Llc |
Methods and compositions for the treatment of myeloproliferative diseases and other proliferative diseases
|
|
CN102408411B
(zh)
|
2011-09-19 |
2014-10-22 |
北京康辰药业股份有限公司 |
一种含喹啉基的羟肟酸类化合物及其制备方法、以及含有该化合物的药物组合物及其应用
|
|
WO2013042137A1
(en)
|
2011-09-19 |
2013-03-28 |
Aurigene Discovery Technologies Limited |
Bicyclic heterocycles as irak4 inhibitors
|
|
WO2013059740A1
(en)
|
2011-10-21 |
2013-04-25 |
Foundation Medicine, Inc. |
Novel alk and ntrk1 fusion molecules and uses thereof
|
|
EP2779833A4
(en)
|
2011-11-14 |
2015-03-18 |
Tesaro Inc |
MODULATION OF SPECIFIC TYROSINE KINASES
|
|
WO2013088257A1
(en)
|
2011-12-12 |
2013-06-20 |
Dr. Reddy's Laboratories Ltd. |
Substituted heterocyclic compounds as tropomyosin receptor kinase a (trka) inhibitors
|
|
RS59420B1
(sr)
|
2011-12-30 |
2019-11-29 |
Hanmi Pharmaceutical Co Ltd |
Derivati tieno[3,2-d]pirimidina sa inhibitornom aktivnošću za proteinske kinaze
|
|
JP2015109806A
(ja)
|
2012-03-22 |
2015-06-18 |
アステラス製薬株式会社 |
新規ｒｅｔ融合体の検出法
|
|
EP2842955B1
(en)
|
2012-04-26 |
2016-10-05 |
ONO Pharmaceutical Co., Ltd. |
Trk-inhibiting compound
|
|
JP2015516439A
(ja)
|
2012-05-10 |
2015-06-11 |
シンタ ファーマシューティカルズ コーポレーション |
Ｈｓｐ９０阻害化合物で癌を治療すること
|
|
JP6231556B2
(ja)
|
2012-05-23 |
2017-11-15 |
ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ |
Ｎ−［５−（３，５−ジフルオロ−ベンジル）−１ｈ−インダゾール−３−イル］−４−（４−メチル−ピペラジン−１−イル）−２−（テトラヒドロ−ピラン−４−イルアミノ）−ベンズアミドの調製方法
|
|
TWI585088B
(zh)
|
2012-06-04 |
2017-06-01 |
第一三共股份有限公司 |
作爲激酶抑制劑之咪唑并［１，２－ｂ］嗒衍生物
|
|
CN104619841A
(zh)
|
2012-07-26 |
2015-05-13 |
日本国立癌症研究中心 |
Cep55基因与ret基因的融合基因
|
|
EP2689778A1
(en)
|
2012-07-27 |
2014-01-29 |
Pierre Fabre Medicament |
Derivatives of azaindoles or diazaindoles for treating pain
|
|
US20150218652A1
(en)
|
2012-08-31 |
2015-08-06 |
The Regents Of The Unversity Of Colorado, A Body Corporate |
Methods for diagnosis and treatment of cancer
|
|
WO2014039971A1
(en)
|
2012-09-07 |
2014-03-13 |
Exelixis, Inc. |
Inhibitors of met, vegfr and ret for use in the treatment of lung adenocarcinoma
|
|
US20140084039A1
(en)
|
2012-09-24 |
2014-03-27 |
Electro Scientific Industries, Inc. |
Method and apparatus for separating workpieces
|
|
TR201815994T4
(tr)
|
2012-09-25 |
2018-11-21 |
Chugai Pharmaceutical Co Ltd |
Ret inhibitörü.
|
|
JP2014082984A
(ja)
|
2012-10-23 |
2014-05-12 |
Astellas Pharma Inc |
新規ｎｔｒｋ２活性化変異の検出法
|
|
US9604980B2
(en)
|
2012-11-07 |
2017-03-28 |
Nerviano Medical Sciences S.R.L. |
Substituted pyrimidinyl and pyridinyl-pyrrolopyridinones, process for their preparation and their use as kinase inhibitors
|
|
EA029706B1
(ru)
|
2012-11-12 |
2018-05-31 |
Игнайта, Инк. |
Сложные алкиловые эфиры бендамустина и способы их применения
|
|
WO2014078328A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
N-bicyclic aryl,n'-pyrazolyl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
|
EP2922844B1
(en)
|
2012-11-13 |
2018-01-10 |
Array Biopharma, Inc. |
N-pyrrolidinyl, n'-pyrazolyl- urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
|
US9809578B2
(en)
|
2012-11-13 |
2017-11-07 |
Array Biopharma Inc. |
Pyrazolyl urea, thiourea, guanidine and cyanoguanidine compounds as trkA kinase inhibitors
|
|
US9790178B2
(en)
|
2012-11-13 |
2017-10-17 |
Array Biopharma Inc. |
Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
|
|
EP2920166B1
(en)
|
2012-11-13 |
2016-11-02 |
Array Biopharma, Inc. |
Bicyclic urea, thiourea, guanidine and cyanoguanidine compounds useful for the treatment of pain
|
|
WO2014078331A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
N-(arylalkyl)-n'-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
|
WO2014078325A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
N-(monocyclic aryl),n'-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
|
US9822118B2
(en)
|
2012-11-13 |
2017-11-21 |
Array Biopharma Inc. |
Bicyclic heteroaryl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
|
|
US9981959B2
(en)
|
2012-11-13 |
2018-05-29 |
Array Biopharma Inc. |
Thiazolyl and oxazolyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
|
|
BR112015002626A2
(pt)
|
2012-11-29 |
2017-09-26 |
Yeda Res & Dev |
métodos para prevenção de metástases tumorais, tratamento e prognostico do câncer e identificação dos agentes que são inibidores da metástase putativa
|
|
WO2014086284A1
(zh)
|
2012-12-04 |
2014-06-12 |
上海医药集团股份有限公司 |
一类氘代3-氰基喹啉类化合物、其药用组合物、制备方法及其用途
|
|
FR3000494B1
(fr)
|
2012-12-28 |
2015-08-21 |
Oribase Pharma |
Nouveaux derives d'azaindoles en tant qu'inhibiteurs de proteines kinases
|
|
CN104995184B
(zh)
|
2012-12-28 |
2018-01-02 |
晶体基因技术株式会社 |
作为btk激酶抑制剂的2,3‑二氢异吲哚‑1‑酮诱导体与含此类的药学组合物
|
|
FR3000492B1
(fr)
|
2012-12-28 |
2015-09-11 |
Oribase Pharma |
Nouveaux derives azaindole en tant qu'inhibiteurs multikinases
|
|
FR3000493A1
(fr)
|
2012-12-28 |
2014-07-04 |
Oribase Pharma |
Nouveaux inhibiteurs de proteines kinases
|
|
US9127055B2
(en)
|
2013-02-08 |
2015-09-08 |
Astellas Pharma Inc. |
Method of treating pain with anti-human NGF antibody
|
|
HUE042591T2
(hu)
|
2013-02-19 |
2019-07-29 |
Ono Pharmaceutical Co |
TRK-gátló vegyület
|
|
EP2981613A4
(en)
|
2013-02-22 |
2016-11-02 |
Boris C Bastian |
FUSION POLYNUCLEOTIDES AND FUSION POLYPEPTIDES RELATED TO CANCER AND IN PARTICULAR TO MELANOMA AND USES THEREOF AS THERAPEUTIC AND DIAGNOSTIC OBJECTIVES
|
|
US20140243332A1
(en)
|
2013-02-27 |
2014-08-28 |
Oregon Health & Science University |
Methods of treating cancers characterized by aberrent ros1 activity
|
|
AU2014229233B2
(en)
|
2013-03-15 |
2016-08-11 |
Glaxosmithkline Intellectual Property Development Limited |
Pyridine derivatives as rearranged during transfection (RET) kinase inhibitors
|
|
AR095308A1
(es)
|
2013-03-15 |
2015-10-07 |
Glaxosmithkline Ip Dev Ltd |
Compuesto de 2-piridona, composición farmacéutica que lo comprende y su uso para preparar un medicamento
|
|
JP2016515508A
(ja)
|
2013-03-15 |
2016-05-30 |
ザ・トラスティーズ・オブ・コロンビア・ユニバーシティ・イン・ザ・シティ・オブ・ニューヨーク |
融合タンパク質及びその方法
|
|
WO2014152777A2
(en)
|
2013-03-15 |
2014-09-25 |
Insight Genetics, Inc. |
Methods and compositions for the diagnosis and treatment of cancers resistant to ros1 inhibitors
|
|
EP3795696B1
(en)
|
2013-03-15 |
2023-04-26 |
The Board of Trustees of the Leland Stanford Junior University |
Identification and use of circulating nucleic acid tumor markers
|
|
CN118910253A
(zh)
|
2013-04-17 |
2024-11-08 |
生命技术公司 |
与癌症相关的基因融合体和基因变异体
|
|
EP3019489A4
(en)
|
2013-07-11 |
2016-12-28 |
Betta Pharmaceuticals Co Ltd |
MODULATORS OF TYROSINE KINASE PROTEIN AND METHODS OF USE
|
|
JP6534930B2
(ja)
|
2013-07-26 |
2019-06-26 |
公益財団法人がん研究会 |
Ｎｔｒｋ３融合体の検出法
|
|
WO2015017533A1
(en)
|
2013-07-30 |
2015-02-05 |
Blueprint Medicines Corporation |
Ntrk2 fusions
|
|
JP6493681B2
(ja)
|
2013-08-20 |
2019-04-03 |
学校法人関西医科大学 |
肺がんで見出された新規融合遺伝子
|
|
EP3039021A1
(en)
|
2013-08-30 |
2016-07-06 |
Ambit Biosciences Corporation |
Biaryl acetamide compounds and methods of use thereof
|
|
AU2014340398A1
(en)
|
2013-10-24 |
2016-06-09 |
Georgetown University |
Methods and compositions for treating cancer
|
|
WO2015064621A1
(ja)
|
2013-10-29 |
2015-05-07 |
公益財団法人がん研究会 |
新規融合体及びその検出法
|
|
US10212896B2
(en)
|
2013-11-27 |
2019-02-26 |
Enplas Corporation |
Emitter, and tube for drip irrigation
|
|
GB201321146D0
(en)
|
2013-11-29 |
2014-01-15 |
Cancer Rec Tech Ltd |
Quinazoline compounds
|
|
US9801880B2
(en)
|
2013-12-02 |
2017-10-31 |
Bergenbio As |
Use of kinase inhibitors
|
|
HRP20191283T1
(hr)
|
2014-01-24 |
2019-10-18 |
Turning Point Therapeutics, Inc. |
Diaril makrocikli kao modulatori protein kinaze
|
|
HUE055357T2
(hu)
|
2014-02-05 |
2021-11-29 |
VM Oncology LLC |
Vegyületek kompozíciói és azok alkalmazásai
|
|
EP3738952A1
(en)
|
2014-02-14 |
2020-11-18 |
Exelixis, Inc. |
Crystalline solid forms of n-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-n'-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, processes for making, and methods of use
|
|
TWI672141B
(zh)
|
2014-02-20 |
2019-09-21 |
美商醫科泰生技 |
投予ｒｏｓ１突變癌細胞之分子
|
|
LT3154959T
(lt)
|
2014-05-15 |
2019-09-25 |
Array Biopharma, Inc. |
1-((3s,4r)-4-(3-fluorfenil)-1-(2-metoksietil)pirolidin-3-il)-3-(4-metil-3-(2-metilpirimidin-5-il)-1-fenil-1h-pirazol-5-il)karbamidas kaip trka kinazės inhibitorius
|
|
WO2015183837A1
(en)
|
2014-05-27 |
2015-12-03 |
Brian Haynes |
Compositions, methods, and uses related to ntrk2-tert fusions
|
|
US20170114415A1
(en)
|
2014-05-30 |
2017-04-27 |
The Regents Of The University Of Colorado, A Body Corporate |
Activating ntrk1 gene fusions predictive of kinase inhibitor therapy
|
|
CN105222097A
(zh)
|
2014-06-26 |
2016-01-06 |
欧普照明股份有限公司 |
一种灯具及其光学模组
|
|
ES2747249T3
(es)
|
2014-07-17 |
2020-03-10 |
Sunshine Lake Pharma Co Ltd |
Derivados de 1-(5-(terc-butil)isoxazol-3-il)-3-(4-((fenil)etinil)fenil)urea y compuestos relacionados como inhibidores de FLT3 para el tratamiento de cáncer
|
|
KR20170042614A
(ko)
|
2014-08-01 |
2017-04-19 |
파마싸이클릭스 엘엘씨 |
Btk 저해제를 이용한 치료에 대한 dlbcl의 반응을 예측하기 위한 바이오마커
|
|
BR122017020365A2
(pt)
|
2014-08-18 |
2019-09-10 |
Ono Pharmaceutical Co |
sal de adição de ácido do composto inibidor de trk
|
|
US20170283404A1
(en)
|
2014-09-08 |
2017-10-05 |
Glaxosmithkline Intellectual Property Development Limited |
Crystalline forms of 2-(4-(4-ethoxy-6-oxo-1,6-dihydropyridin-3-yl)-2-fluorophenyl)-n-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)acetamide
|
|
MX381233B
(es)
|
2014-09-10 |
2025-03-12 |
Glaxosmithkline Ip Dev Ltd |
Nuevos compuestos como inhibidores de reorganizado durante la transfección (ret).
|
|
RS58813B1
(sr)
|
2014-09-10 |
2019-07-31 |
Glaxosmithkline Ip Dev Ltd |
Piridonski derivati korišćeni kao inhibitori kinaze reorganizovane tokom transfekcije (ret)
|
|
TWI538914B
(zh)
|
2014-10-03 |
2016-06-21 |
國立交通大學 |
蛋白質激酶之選擇性抑制劑、其醫藥組成物及其用途
|
|
UY36351A
(es)
|
2014-10-14 |
2016-06-01 |
Novartis Ag |
Moléculas de anticuerpo que se unen a pd-l1 y usos de las mismas
|
|
EP3218380B1
(en)
|
2014-11-16 |
2021-03-17 |
Array Biopharma, Inc. |
Preparation of a crystalline form of (s)-n-(5-((r)-2-(2,5-difluorophenyl)-pyrrolidin-1-yl)-pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide hydrogen sulfate
|
|
CN107207514B
(zh)
|
2014-12-15 |
2020-01-24 |
康联制药有限公司 |
稠环杂芳基化合物及其作为trk抑制剂的用途
|
|
WO2016096709A1
(en)
|
2014-12-16 |
2016-06-23 |
Eudendron S.R.L. |
Heterocyclic derivatives modulating activity of certain protein kinases
|
|
WO2016127074A1
(en)
|
2015-02-06 |
2016-08-11 |
Blueprint Medicines Corporation |
2-(pyridin-3-yl)-pyrimidine derivatives as ret inhibitors
|
|
KR101675984B1
(ko)
|
2015-02-23 |
2016-11-14 |
한양대학교 에리카산학협력단 |
티에노디아제핀 유도체 또는 이의 약학적으로 허용가능한 염, 및 이를 유효성분으로 포함하는 약학적 조성물
|
|
CA2978628A1
(en)
|
2015-03-03 |
2016-09-09 |
Caris Mpi, Inc. |
Molecular profiling for cancer
|
|
WO2016149261A1
(en)
|
2015-03-16 |
2016-09-22 |
Personal Genome Diagnostics, Inc. |
Systems and methods for analyzing nucleic acid
|
|
WO2016168992A1
(en)
|
2015-04-21 |
2016-10-27 |
Ruijin Hospital Affiliated To Shanghai Jiao Tong University School Of Medicine |
Preparation and use of novel protein kinase inhibitors
|
|
MX2017014700A
(es)
|
2015-05-20 |
2018-08-15 |
Broad Inst Inc |
Neoantigenos compartidos.
|
|
WO2016196141A1
(en)
|
2015-05-29 |
2016-12-08 |
Ignyta, Inc. |
Compositions and methods for treating patients with rtk mutant cells
|
|
PE20180329A1
(es)
|
2015-06-01 |
2018-02-13 |
Loxo Oncology Inc |
Metodos para diagnosticar y tratar el cancer
|
|
AU2015101722A4
(en)
|
2015-06-19 |
2016-05-19 |
Macau University Of Science And Technology |
Oncogenic ros1 and alk kinase inhibitor
|
|
US9782400B2
(en)
|
2015-06-19 |
2017-10-10 |
Macau University Of Science And Technology |
Oncogenic ROS1 and ALK kinase inhibitor
|
|
GB201511546D0
(en)
|
2015-07-01 |
2015-08-12 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
|
|
AU2016287568B2
(en)
|
2015-07-02 |
2020-08-20 |
Turning Point Therapeutics, Inc. |
Chiral diaryl macrocycles as modulators of protein kinases
|
|
GB201512365D0
(en)
|
2015-07-15 |
2015-08-19 |
King S College London |
Novel therapy
|
|
PT3322706T
(pt)
|
2015-07-16 |
2021-03-08 |
Array Biopharma Inc |
Compostos de pirazolo[1,5-a]piridina substituídos como inibidores da quinase do ret
|
|
EP3120851A1
(en)
|
2015-07-21 |
2017-01-25 |
Pangaea Biotech S.L. |
4-amino-6-(2,6-dichlorophenyl)-8-methyl-2-(phenylamino)-pyrido[2,3-d]pyrimidin-7(8h)-one for treatment of solid cancers
|
|
KR101766194B1
(ko)
|
2015-08-07 |
2017-08-10 |
한국과학기술연구원 |
RET 키나아제 저해제인 신규 3-(이속사졸-3-일)-피라졸로[3,4-d]피리미딘-4-아민 화합물
|
|
US10550124B2
(en)
|
2015-08-13 |
2020-02-04 |
San Diego State University Foundation |
Atropisomerism for increased kinase inhibitor selectivity
|
|
MA41559A
(fr)
|
2015-09-08 |
2017-12-26 |
Taiho Pharmaceutical Co Ltd |
Composé de pyrimidine condensé ou un sel de celui-ci
|
|
WO2017049462A1
(zh)
|
2015-09-22 |
2017-03-30 |
合肥中科普瑞昇生物医药科技有限公司 |
一类新型的flt3激酶抑制剂及其用途
|
|
CN105255927B
(zh)
|
2015-09-30 |
2018-07-27 |
温州医科大学附属第一医院 |
一种kiaa1217-ret融合基因
|
|
TN2019000271A1
(en)
|
2015-10-26 |
2021-01-07 |
Univ Colorado Regents |
Point mutations in trk inhibitor-resistant cancer and methods relating to the same
|
|
EP3371171B1
(en)
|
2015-11-02 |
2023-10-25 |
Blueprint Medicines Corporation |
Inhibitors of ret
|
|
US20190002988A1
(en)
|
2015-12-08 |
2019-01-03 |
Boehringer Ingelheim International Gmbh |
Method of using a ret fusion gene as a biomarker to select non small cell lung cancer (nsclc) and thyroid cancer patients for a cancer treatment
|
|
WO2017122815A1
(ja)
|
2016-01-15 |
2017-07-20 |
公益財団法人がん研究会 |
新規融合体及びその検出法
|
|
WO2017127835A2
(en)
|
2016-01-22 |
2017-07-27 |
The Medicines Company |
Aqueous formulations and methods of preparation and use thereof
|
|
TWI620748B
(zh)
|
2016-02-05 |
2018-04-11 |
National Health Research Institutes |
氨基噻唑化合物及其用途
|
|
ES2775751T3
(es)
|
2016-02-23 |
2020-07-28 |
Taiho Pharmaceutical Co Ltd |
Nuevo compuesto de pirimidina condensada o sal del mismo
|
|
WO2017145050A1
(en)
|
2016-02-23 |
2017-08-31 |
Glaxosmithkline Intellectual Property Development Limited |
Pyridylpyridone derivative useful as a ret kinase inhibitor in the treatment of ibs and cancer
|
|
WO2017155018A1
(ja)
|
2016-03-11 |
2017-09-14 |
小野薬品工業株式会社 |
Ｔｒｋ阻害剤抵抗性の癌治療剤
|
|
WO2017161269A1
(en)
|
2016-03-17 |
2017-09-21 |
Blueprint Medicines Corporation |
Inhibitors of ret receptor tyrosine kinases
|
|
IL304018A
(en)
|
2016-04-04 |
2023-08-01 |
Loxo Oncology Inc |
Liquid formulations of (S)-N-(5-((R)-2-(5,2-difluorophenyl)-pyrrolidine-1-yl)-pyrazolo[5,1-A]pyrimidin-3-yl)-3 -hydroxypyrrolidine-1-carboxamide
|
|
US10045991B2
(en)
|
2016-04-04 |
2018-08-14 |
Loxo Oncology, Inc. |
Methods of treating pediatric cancers
|
|
IL297192A
(en)
|
2016-04-15 |
2022-12-01 |
Cancer Research Tech Ltd |
Heterocyclic compounds as ret kinase inhibitors
|
|
SMT202200348T1
(it)
|
2016-04-15 |
2022-11-18 |
Cancer Research Tech Ltd |
Composti eterociclici come inibitori della chinasi ret
|
|
EP3445361A1
(en)
|
2016-04-19 |
2019-02-27 |
Exelixis, Inc. |
Triple negative breast cancer treatment method
|
|
WO2017197051A1
(en)
|
2016-05-10 |
2017-11-16 |
C4 Therapeutics, Inc. |
Amine-linked c3-glutarimide degronimers for target protein degradation
|
|
ES2952056T3
(es)
|
2016-05-18 |
2023-10-26 |
Loxo Oncology Inc |
Preparación de (s)-n-(5-((r)-2-(2,5-difluorofenil)pirrolidin-1-il)pirazolo[1,5-a]pirimidin-3-il)-3-hidroxipirrolidina-1-carboxamida
|
|
WO2017201156A1
(en)
|
2016-05-18 |
2017-11-23 |
Duke University |
Method of treating kras wild-type metastatic colorectal cell carcinoma using cabozantinib plus panitumumab
|
|
WO2017207696A1
(en)
|
2016-06-01 |
2017-12-07 |
F. Hoffmann-La Roche Ag |
Novel mutations in anaplastic lymphoma kinase predicting response to alk inhibitor therapy in lung cancer patients
|
|
US10227329B2
(en)
|
2016-07-22 |
2019-03-12 |
Blueprint Medicines Corporation |
Compounds useful for treating disorders related to RET
|
|
TWI704148B
(zh)
|
2016-10-10 |
2020-09-11 |
美商亞雷生物製藥股份有限公司 |
作為ｒｅｔ激酶抑制劑之經取代吡唑并[1,5-a]吡啶化合物
|
|
JOP20190092A1
(ar)
|
2016-10-26 |
2019-04-25 |
Array Biopharma Inc |
عملية لتحضير مركبات بيرازولو[1، 5-a]بيريميدين وأملاح منها
|
|
MX389966B
(es)
|
2017-01-20 |
2025-03-20 |
Exelixis Inc |
Combinaciones de cabozantinib y atezolizumab para tratar cancer.
|
|
CN108456163A
(zh)
|
2017-02-20 |
2018-08-28 |
中国科学院上海药物研究所 |
含邻氨基杂芳环炔基的化合物及其制备方法和用途
|
|
JOP20190213A1
(ar)
|
2017-03-16 |
2019-09-16 |
Array Biopharma Inc |
مركبات حلقية ضخمة كمثبطات لكيناز ros1
|
|
US20190247398A1
(en)
|
2017-10-26 |
2019-08-15 |
Array Biopharma Inc. |
Formulations of a macrocyclic trk kinase inhibitor
|